U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT06929260) titled 'A Study to Evaluate the Effect of Ceralasertib on Drug X, Drug Y and Drug Z' on April 14.
Brief Summary: The study aims to assess the effect of ceralasertib on the pharmacokinetics (PK) of Drug X, Drug Y and Drug Z in participants with advanced solid tumours.
Study Start Date: April 22
Study Type: INTERVENTIONAL
Condition:
Advanced Solid Tumours
Intervention:
DRUG: Ceralasertib
Participants will receive repeated dosing of ceralasertib from Day 1 to Day 7 until steady state.
DRUG: Drug X
Participants will receive a single dose of Drug X on Day 5 and Day 22.
DRUG: Drug Y
Participants will receive a single dose of Drug Y on...